Launch of New Advanced Breast Cancer (ABC) Global Charter

Food and Healthcare Press Releases Tuesday October 31, 2017 08:01
LISBON, Portugal--31 Oct--PRNewswire/InfoQuest
A multi-stakeholder initiative setting out 10 goals to change the future of advanced breast cancer by 2025

The Advanced Breast Cancer (ABC) Global Alliance has launched the ABC Global Charter[i] , a bold new initiative setting out 10 clear goals to drive global improvements in ABC care and survival by 2025. The ABC Global Charter addresses the most urgent and actionable gaps in the treatment and care of patients with ABC to ultimately improve and extend their lives. The ABC Global Alliance, a European School of Oncology backed, multi-stakeholder platform initiated in 2016, will push forward the ABC Global Charter encouraging the worldwide breast cancer community, policy makers and the public to unite to help change the future of ABC patients.

(Logo: http://mma.prnewswire.com/media/591998/ABC_Global_Alliance_Logo.jpg )

Much progress has been made in the diagnosis, management and outcomes of early breast cancer, however major gaps still exist in the treatment and management of ABC and median survival has remained stubbornly stuck at two to three years after diagnosis, with 50% of cases and 58% of deaths occurring in less developed countries.

"The care of ABC has lagged behind that of early breast cancer with too many people still dying too early and change is urgently needed", comments Fatima Cardoso, director of the Breast Unit, Champalimaud Clinical Centre, Lisbon, Portugal and Chair of the ABC Global Alliance. "The ABC Global Charter is an ambitious charter for change. Our goal is to unite the ABC community to work together towards common, achievable goals at international and local levels."

The Charter centres on 10 Actions for Change addressing gaps in ABC research, ABC patient care and ABC in society as identified by the Global Status of Advanced/Metastatic Breast Cancer: 2005-2015 Decade Report[ii] which led to the preliminary mBC Vision 2025 'Call-to-Action'.

The 10 Actions for Change:
1. Double median overall survival for patients with ABC to at least 4 years by 2025
2. Improve quality of life for ABC patients in clinical practice
3. Improve availability of robust epidemiology and outcomes data for ABC

4. Increase availability and access to multidisciplinary care, including palliative, supportive, and psychosocial assistance for patients, families, and caregivers to ensure patients are receiving the best treatment experience

5. Strive for all patients with ABC to have financial support for treatment, care and assistance if unable to work
6. Offer communication skills training to all healthcare providers
7. Provide accurate and up-to-date ABC-specific information tools to all patients who want them
8. Increase public understanding of ABC
9. Improve access to non-clinical supportive services for ABC
10. Protect workforce rights for patients with ABC
The Actions for Change will be discussed in detail at the first ABC Global Alliance meeting on 4-5 November 2017 in Lisbon which follows the ABC4 Conference.
For more details see www.abcglobalalliance.org
References
i. ABC Global Charter.http://www.abcglobalalliance.org/abc-global-alliance-charter/
ii. Pfizer Inc. Global Status of Advanced/Metastatic Breast Cancer: 2005-2015 Decade Report. http://breastcancervision.com . Published March 2016 Accessed [March 2017]
Roberta Ventura
Managing Coordinator ABC Global Alliance
Telephone: +41-91-820-0957
Email: rventura@eso.net
Source: ABC Global Alliance

Latest Press Release

Covaris Introduces the 96 oneTUBE-10 AFA Plate for Improved NGS Workflows

Today, Covaris Inc. announced the release of the 96 oneTUBE-10 AFA Plate, which enables scalable and simplified workflows by leveraging Covaris' gold standard focused-acoustic technology to meet rapidly increasing Next-Generation Sequencing (NGS) demands...

2018 Empire State Building Run-Up Lottery Registration Opens on November 14, 2017

Runners must enter by December 10 for a chance to participate in the 41st Annual Run-Up on Wednesday, February 7, 2018, at 8:00 p.m. Empire State Realty Trust, Inc. (NYSE: ESRT) today announced that lottery registration for the 2018 Empire State...

Alpinion Medical Systems Launches E-CUBE 8, the New Ultrasound Diagnostic System

One of South Korea's global medical device manufacturers, Alpinion Medical Systems introduced its new E-CUBE 8, the latest and last addition to the E-CUBE lineup. The E-CUBE 8 is a smart, reliable product that ensures high performance with outstanding...

Photo Release: The Royal Danish Embassy and Novo Nordisk Pharma (Thailand) Co., Ltd launch the Blueprint for Change address Diabetes challenge , aligned with national NCD targets

On the 5th November 2017, right after the WDD event at the Vachirabenjatas Park (Suan Rot Fai Park) . Mr.Uffe Wolffhechel, the ambassador of the Royal Danish Embassy, Thailand (right) together with Mr.Mihai Irimescu, General Manager of Novo Nordisk...

Stryker announces publication of the DAWN(TM) Trial results in the New England Journal of Medicine

The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy. Currently, less than one in 10 patients suffering from...

Related Topics